Technical Analysis for NRSN - NeuroSense Therapeutics Ltd.

Grade Last Price % Change Price Change
D 2.39 -3.24% -0.08
NRSN closed down 3.24 percent on Thursday, January 20, 2022, on approximately normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong N/A N/A Down
Historical NRSN trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New Downtrend Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -3.24%
Hot IPO Pullback Bullish Swing Setup -3.24%
Wide Bands Range Expansion -3.24%
20 DMA Support Bullish -13.41%
Older End-of-Day Signals for NRSN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 17 hours ago
Up 1% about 17 hours ago
2x Volume Pace about 18 hours ago
1.5x Volume Pace about 18 hours ago
3x Volume Pace about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeuroSense Therapeutics is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. NeuroSense believes that these diseases, which include ALS, Alzheimer's disease and Parkinson's disease, among others, represent one of the most significant unmet medical needs of our time, with limited effective therapeutic options available for patients. Due to the complexity of neurodegenerative diseases, NeuroSense's strategy is to develop combined therapies targeting multiple pathways associated with these diseases.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Disease Neuroscience Alzheimer's Disease Parkinson's Disease Neurodegenerative Diseases Neurodegeneration Senescence Gladstone Institutes

Is NRSN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.6998
52 Week Low 2.32
Average Volume 263,736
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 2.67
10-Day Moving Average 2.60
Average True Range 0.29
ADX 57.67
+DI 10.80
-DI 28.29
Chandelier Exit (Long, 3 ATRs) 2.61
Chandelier Exit (Short, 3 ATRs) 3.20
Upper Bollinger Bands 3.12
Lower Bollinger Band 2.22
Percent B (%b) 0.19
BandWidth 33.50
MACD Line -0.20
MACD Signal Line -0.18
MACD Histogram -0.0166
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.68
Resistance 3 (R3) 2.68 2.60 2.63
Resistance 2 (R2) 2.60 2.52 2.59 2.61
Resistance 1 (R1) 2.49 2.48 2.45 2.49 2.60
Pivot Point 2.41 2.41 2.39 2.40 2.41
Support 1 (S1) 2.30 2.33 2.26 2.30 2.18
Support 2 (S2) 2.22 2.29 2.21 2.17
Support 3 (S3) 2.11 2.22 2.15
Support 4 (S4) 2.11